These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23936798)

  • 1. Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells.
    Yue Y; Shao Y; Luo Q; Shi L; Wang Z
    Biomed Res Int; 2013; 2013():434561. PubMed ID: 23936798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
    Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
    Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
    Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
    Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
    Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
    Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113.
    Shao Y; Sha XY; Bai YX; Quan F; Wu SL
    Mol Med Rep; 2015 Jan; 11(1):212-8. PubMed ID: 25333745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
    Doberstein K; Pfeilschifter J; Gutwein P
    Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression.
    Gao J; Yin X; Yu X; Dai C; Zhou F
    J Cell Biochem; 2019 Oct; 120(10):16393-16407. PubMed ID: 31270840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma.
    Yang CL; Jiang FQ; Xu F; Jiang GX
    Tumour Biol; 2012 Oct; 33(5):1535-41. PubMed ID: 22581584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
    Zhang W; Liu S; Liu K; Wang Y; Ji B; Zhang X; Liu Y
    J Int Med Res; 2014 Jun; 42(3):611-8. PubMed ID: 24670536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of ANXA7 decreases metastatic potential of human hepatocellular carcinoma cells in vitro.
    Ibrahim MM; Sun MZ; Huang Y; Jun M; Jin Y; Yue D; Jiasheng W; Zhang J; Qazi AS; Sagoe K; Tang J
    Biomed Pharmacother; 2013 May; 67(4):285-91. PubMed ID: 23582794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
    Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
    Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon-induced transmembrane protein 3 knock-down inhibits proliferation and invasion of hepatocellular carcinoma HepG2 cells in vitro].
    Wu RS; Wu LQ; Li KH; Li EL; Feng Q; Zhang JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):244-9. PubMed ID: 26922024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.
    Fu L; Liu N; Han Y; Xie C; Li Q; Wang E
    Tumour Biol; 2014 Sep; 35(9):9263-8. PubMed ID: 24935471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.